Joseph S McCracken Insider Trading
Get free email notifications about insider trading for Joseph S McCracken.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Joseph S McCracken. Joseph S McCracken is a Director in Savara Inc ($MSTX) and a Director in LUMOS PHARMA, INC. ($NLNK) and a Director in Kindred Biosciences, Inc. ($KIN) and a Director in Nexvet Biopharma plc ($NVET).
Address: C/O NEXVET BIOPHARMA PLC NATL INST, FOSTERS AVENUE, MOUNT MERRION BLACKROCK 00000Ireland
Companies in which Joseph S McCracken is an Insider
Kindred Biosciences, Inc.
Trading Symbol: KINIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Joseph S McCracken: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 22 2021
$KIN Market Capitalization: $126.31M
$KIN Previous Close: $6.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
LUMOS PHARMA, INC.
Trading Symbol: NLNKIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Joseph S McCracken: Director
Holdings: 709 shares
Current Value: $9,692
Latest Transaction: Apr 07 2020
$NLNK Market Capitalization: $408.17M
$NLNK Previous Close: $13.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Nexvet Biopharma plc
Trading Symbol: NVETIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Joseph S McCracken: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Aug 02 2017
$NVET Market Capitalization: $40.45M
$NVET Previous Close: $3.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Savara Inc
Trading Symbol: SVRAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Joseph S McCracken: Director
Holdings: 168,337 shares
Current Value: $23,567
Latest Transaction: Mar 15 2021
$SVRA Market Capitalization: $32.99M
$SVRA Previous Close: $0.14
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Joseph S McCracken
Sentiment: All, KIN, NLNK, NVET, SVRA
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 15 2021 | SVRA | Savara Inc | McCracken Joseph S | Director | Buy | P | 1.45 | 68,965 | 99,999 | 168,337 | 99.4 K to 168.3 K (+69.40 %) |
Jan 22 2021 | KIN | Kindred Bioscience ... | McCracken Joseph S | Director | Option Exercise | A | 4.44 | 48,500 | 215,340 | 48,500 | |
Dec 17 2020 | SVRA | Savara Inc | McCracken Joseph S | Director | Option Exercise | A | 1.23 | 40,000 | 49,200 | 40,000 | |
Apr 07 2020 | NLNK | LUMOS PHARMA, INC. | McCracken Joseph S | Director | Option Exercise | A | 7.78 | 5,684 | 44,222 | 5,684 | |
Apr 07 2020 | NLNK | LUMOS PHARMA, INC. | McCracken Joseph S | Director | Grant | A | 0.00 | 709 | 0 | 709 | 0 to 709 |
Jan 22 2020 | KIN | Kindred Bioscience ... | McCracken Joseph S | Director | Option Exercise | A | 9.84 | 48,500 | 477,240 | 48,500 | |
Jan 22 2020 | KIN | Kindred Bioscience ... | McCracken Joseph S | Director | Option Exercise | A | 9.84 | 48,500 | 477,240 | 48,500 |